SCHEMBL13064708

SCHEMBL13064708

CCC(C)(C)Cc1cccc(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.51
IDO1 P14902 2/20 0.51
AGXT P21549 2/20 0.51
CHRM2 P08172 2/20 0.49
CHRM1 P11229 2/20 0.49
CHRM3 P20309 2/20 0.49
CMA1 P23946 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
AOC3 Q16853 1/20 0.46
MAOB P27338 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
CTBP2 P56545 1/20 0.45
LPO P22079 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23222184 0.88 TAAR1 (0.50) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL29557981 0.84 TAAR1 (0.59) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL20746169 0.84 TAAR1 (0.59) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL73635 0.83 TAAR1 (0.56) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL12384164 0.83 TAAR1 (0.57) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL13064724 0.81 CHRM2 (0.48) CHRM2CHRM1CHRM3
SCHEMBL227359 0.81 ALDH1A1 (0.49) ALDH1A1CTBP2
SCHEMBL10293222 0.81 ALDH1A1 (0.46) ALDH1A1CYP3A4
SCHEMBL5222385 0.80 TAAR1 (0.58) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL8325279 0.80 TAAR1 (0.53) TAAR1IDO1AGXTCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170136007-A1 NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF THE FEINSTEIN INST MEDICAL RES (US) 2017-05-18 US disclosed
US-9650379-B2 Azaindole derivatives as selective histone deacetylase (HDAC) inhibitors and pharmaceutical compositions comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-05-16 US disclosed
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170136007-A1 NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF CHRNA7, CHRNA5, CHRM5 TAAR1 180/4885IDO1 1523/4885AGXT 4795/4885
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES DDT, ACHE, TPM3 TAAR1 130/4885IDO1 515/4885AGXT 2123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.